Schedule: Weekly subcutaneous injections for 1248 weeks (clinical trials ranged 3648 weeks) [2]
There is no MHRA-approved reconstitution calculator for retatrutide, and no such tool has been validated for patient use in the UK
Their effects on weight loss may be due to other mechanisms and methods of administration
Recommended daily intake for adults is 1.5 micrograms according to UK dietary reference values
The assessment of results was made at 24 and 96 hours after peptide administration and included changes in the kidneys on a scale from 0 to 3, where: 0 - healthy kidney, 1 - mild hydronephrosis, 2 - moderate hydronephrosis, visible dilation of the renal pelvis, few changes on the kidney surface, 3 - severe hydronephrosis, dilation of the renal pelvis, thinning of the renal parenchyma, and a significant number of changes on the kidney surface